These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Changes in aortic water and sodium contents associated with potassium supplement in DOCA-salt rats.
    Author: Sato Y, Ito Y, Fujita T.
    Journal: Clin Exp Hypertens A; 1986; 8(3):425-39. PubMed ID: 3524909.
    Abstract:
    Since waterlogging, increased vascular water and sodium contents, could contribute to the development of deoxycorticosterone acetate (DOCA)-salt hypertension, we have examined the effect of dietary potassium supplementation on the water and sodium contents of abdominal aorta after short-term (one week) treatment with DOCA while receiving a 1% NaC1 solution to drink. Supplementation with 1% KC1 solution could counteract the blood-pressure rising action of DOCA-salt, associated with the inhibition of sodium retention. In addition, treatment with DOCA-salt was associated with increases in water (83.1 +/- 3.0% wet weight) and sodium (118.7 +/- 2.8 microEq/g dry weight) contents of the aorta compared with those of the control rats (69.7 +/- 0.3% wet weight and 103.0 +/- 4.0 microEq/g dry weight, respectively). In contrast, 1% KC1 supplementation could attenuate the increase in water (73.2 +/- 1.5% wet weight) and sodium (110.3 +/- 2.3 microEq/g dry weight) contents of the aorta in DOCA-salt rats. Taken together, these results suggest that potassium supplement not only attenuates the sodium retention but also moderates the "waterlogging" in the vascular wall in DOCA-salt rats, thus leading to the antihypertensive action of potassium supplement in the early stage of DOCA-salt hypertension.
    [Abstract] [Full Text] [Related] [New Search]